Stock listing

NASDAQ:GNLX Genelux Corporation Stock

Home listing (NASDAQ) of Genelux Corporation

Follow Genelux Corporation into a list and get an email when it puts out news.

Share price · NASDAQ:GNLX

$2.17 USD -0.07 (-3.1%)

Close on Nov 20, 2026

Past year -53.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$2.12 – $2.41 USDNov 20, 2026
Volume
316,371 sharesNov 20, 2026
Market cap
$104.3M USDAt the close on Nov 20, 2026 · price × 48.06M shares outstanding
52-week range
$1.77 – $5.89 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$777,957 USDMedian day 278,256 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Genelux Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:GNLX · Home$2.17 USD-0.07 (-3.1%)316,371$2.27$2.41$2.12$2.24Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:GNLX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.17-0.07-3.1%$2.27$2.41$2.12316,371
$2.24+0.24+12.0%$2.00$2.29$2.00801,127
$2.00+0.08+4.2%$1.84$2.05$1.82251,278
$1.92+0.055+2.9%$1.94$2.02$1.855277,009
$1.865-0.035-1.8%$1.92$1.96$1.83179,403
$1.90+0.02+1.1%$1.88$1.95$1.81137,319
$1.88-0.07-3.6%$1.97$2.00$1.86292,410
$1.95-0.12-5.8%$2.01$2.10$1.9293,183
$2.07+0.11+5.6%$2.03$2.09$1.935234,713
$1.96+0.14+7.7%$1.83$2.02$1.81323,773
$1.82-0.14-7.1%$1.94$1.94$1.77228,582
$1.96+0.04+2.1%$1.95$2.01$1.862310,505
$1.92-0.08-4.0%$2.01$2.065$1.91287,998
$2.00-0.08-3.8%$2.11$2.18$1.952523,901
$2.08-0.02-1.0%$2.07$2.11$2.00209,629
$2.10-0.11-5.0%$2.27$2.27$2.085120,301
$2.21+0.16+7.8%$2.06$2.24$1.98523,908
$2.05+0.14+7.3%$1.92$2.07$1.861,451,693
$1.91-0.09-4.5%$2.00$2.12$1.87494,700
$2.00+0.02+1.0%$2.02$2.07$1.90648,745
$1.98-0.09-4.3%$2.04$2.35$1.96947,444
$2.07-0.43-17.2%$2.53$2.57$2.018850,725
$2.50+0.05+2.0%$2.43$2.612$2.43331,726
$2.45+0.03+1.2%$2.42$2.47$2.40161,491
$2.42-0.06-2.4%$2.48$2.52$2.355277,873
$2.48+0.16+6.9%$2.40$2.51$2.33796,526
$2.32-0.20-7.9%$2.48$2.52$2.32410,559
$2.52-0.025-1.0%$2.53$2.54$2.485151,876
$2.545-0.015-0.6%$2.59$2.59$2.5172,617
$2.56+0.06+2.4%$2.48$2.57$2.47154,650
$2.50-0.02-0.8%$2.47$2.53$2.42259,115
$2.52-0.02-0.8%$2.52$2.59$2.46550,979
$2.54-0.06-2.3%$2.58$2.63$2.5277,647
$2.60+0.04+1.6%$2.55$2.66$2.465317,345
$2.56+0.04+1.6%$2.55$2.59$2.515278,256
$2.52-0.01-0.4%$2.53$2.56$2.46200,900
$2.53+0.08+3.3%$2.47$2.55$2.47236,870
$2.45-0.02-0.8%$2.48$2.56$2.415164,897
$2.47-0.01-0.4%$2.46$2.50$2.41103,751
$2.48+0.05+2.1%$2.47$2.54$2.42139,873
$2.43-0.085-3.4%$2.51$2.524$2.41151,993
$2.515-0.095-3.6%$2.61$2.64$2.50115,792
$2.61+0.05+2.0%$2.55$2.63$2.52161,803
$2.56+0.03+1.2%$2.57$2.585$2.51197,287
$2.530.000.0%$2.54$2.565$2.504143,118
$2.53+0.19+8.1%$2.36$2.56$2.36295,280
$2.34-0.13-5.3%$2.47$2.47$2.31661,722
$2.47-0.07-2.8%$2.61$2.61$2.40203,404
$2.54+0.05+2.0%$2.49$2.61$2.46297,586
$2.49+0.01+0.4%$2.53$2.55$2.448146,907
$2.48-0.04-1.6%$2.55$2.73$2.41535,584
$2.52-0.02-0.8%$2.50$2.555$2.485114,099
$2.54+0.10+4.1%$2.50$2.54$2.39408,292
$2.44-0.08-3.2%$2.52$2.535$2.425296,534
$2.52-0.03-1.2%$2.55$2.58$2.46510,440
$2.55-0.05-1.9%$2.58$2.635$2.55158,137
$2.60-0.015-0.6%$2.63$2.66$2.56194,989
$2.615-0.045-1.7%$2.67$2.77$2.56328,487
$2.66-0.22-7.6%$2.87$2.87$2.65417,797
$2.88+0.15+5.5%$2.72$2.95$2.72594,425
$2.73+0.01+0.4%$2.73$2.756$2.64300,182
$2.720.000.0%$2.73$2.82$2.67352,906
$2.720.000.0%$2.70$2.77$2.57361,056
$2.72-0.02-0.7%$2.78$2.81$2.684223,747
$2.74+0.06+2.2%$2.72$2.80$2.62405,118
Ticker
NASDAQ:GNLX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Genelux Corporation news

Genelux Corporation on 6ix

Sector
Health care
Industry
Biotechnology
News releases
13 in the last 12 months · 42 in all · newest Nov 16, 2026 · oldest 2023
Decks
17 decks · latest August 2026

Where Genelux Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:GNLX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:GNLXBOATSUnited StatesUSD

Valuation

EV/sales 11,732× against a median of 22.3×: the highest of 7 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$93.85M USD
P/E
Loss
EV/sales
11,732×
EV/EBITDA
Negative EBITDA
Price/book
11.4×
Gross margin
Revenue too small
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta vs S&P 500
1.52

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Genelux Corporation · NASDAQ:GNLXUS$104.3MUS$93.85Mn/a11,732×n/a11.4×n/a0.0×1.52
Jyong Biotech Ltd. · NASDAQ:MENSUS$107.6MUS$125.0Mn/an/an/an/an/an/a1.74
Nykode Therapeutics ASA · OSL:NYKDUS$107.0MUS$62.24Mn/an/an/a1.3×n/a0.0×n/a
JW (Cayman) Therapeutics Co. Ltd. · HKEX:2126US$105.3MUS$84.72Mn/a2.0×n/a1.6×−195.8%0.6×n/a
Cardiol Therapeutics Inc. Class A · TSX:CRDLUS$103.4MUS$83.06Mn/an/an/a5.4×n/a0.0×1.45
Heidelberg Pharma AG · XETR:HPHAUS$103.2MUS$81.75Mn/a8.0×n/an/a−320.9%n/an/a
Foghorn Therapeutics Inc. · NASDAQ:FHTXUS$103.1M−US$9.22M10.9×−0.1×−2.5×n/a8.4%n/a1.57
Vivani Medical, Inc. · NASDAQ:VANIUS$102.8MUS$88.24Mn/an/an/a7.8×n/a0.0×0.93
Paradigm Biopharmaceuticals Ltd. · ASX:PARUS$101.6MUS$96.33Mn/a1,816×n/a44.2×n/a2.2×n/a
Innate Pharma SA Class A · EURONEXT:IPHUS$101.5MUS$111.7Mn/a36.5×n/an/an/an/an/a
BRIM Biotechnology, Inc. · TWSE:6885US$100.3MUS$70.71Mn/a220×n/a2.1×n/a0.0×n/a
Median of the othersUS$103.2MUS$83.89M10.9×22.3×−2.5×3.8×−195.8%0.0×1.51

Forecasts

5 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
18.83 USD · Analysts' mean
EPS, year to Dec 2026
-0.86 · 4 analysts

Team and board

Officers

OfficerRole
Thomas ZindrickPresident and Chief Executive Officer
Matt PulisicChief Financial Officer
Eric GroenGeneral Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
Qian ZhangVice President, Clinical Sciences
Ralph SmallingVice President, Head of Regulatory Affairs
Jason LittenChief Medical Officer
Joseph CappelloChief Technical Officer
Tony YuChief Scientific Officer

Board

DirectorRole
Thomas ZindrickPresident and Chief Executive Officer
James L. TyreeLead Independent Director
John SmitherChair, Compensation Committee
John ThomasChair, Audit Committee
Mary MirabelliChair, Nominating and Corporate Governance Committee

Events

QuarterResultsShare move
Q3 2026Nov 16, 2026 · After close+4.2%
Q2 2026Aug 13, 2026 · After close+4.2%
Q1 2026May 7, 2026 · After close+9.9%
Q4 2025Mar 20, 2026−2.4%
Q3 2025Nov 5, 2025−34.6%
Q2 2025Aug 7, 2025−12.3%
Q1 2025May 6, 2025 · After close−0.4%
Q4 2024Mar 28, 2025−10.9%
Q3 2024Nov 14, 2024 · After close−19.7%
Q2 2024Aug 14, 2024 · After close+1.9%
All 18 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · After close−4.7%
Q4 2023Mar 29, 2024 · After close−18.5%
Q3 2023Nov 14, 2023 · After close−7.6%
Q2 2023Aug 14, 2023 · Before open−1.3%
Q1 2023May 15, 2023 · Before open−9.1%
Q4 2022Mar 29, 2023 · After close+2.6%
Q2 2022Sep 19, 2022
Q1 2022Jun 24, 2022

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2026)Investor deck46 slidesAugust 2026
Investor Presentation (February 2026)Investor deck45 slidesFeb 2, 2026
Investor Presentation (March 2025)Investor deck43 slidesMar 25, 2025
Investor Presentation (November 2024)Investor deck41 slidesNov 8, 2024
Investor Presentation (August 2024)Investor deck28 slidesAug 1, 2024
Investor Presentation (June 2024)Investor deck40 slidesJun 5, 2024
Investor Presentation (May 2024)Investor deck40 slidesMay 24, 2024
Investor Presentation (April 2024)Investor deck40 slidesApr 9, 2024
Investor Presentation (April 2024)Investor deck39 slidesApr 2, 2024
Investor Presentation (February 2024)Investor deck37 slidesFeb 5, 2024
All 17 decks
DeckKindSlidesDate
Investor Presentation (December 2023)Investor deck37 slidesDec 12, 2023
Investor Presentation (October 2023)Investor deck38 slidesOct 10, 2023
Investor Presentation (July 2023)Investor deck38 slidesJul 19, 2023
Investor Presentation (June 2023)Investor deck33 slidesJun 27, 2023
IPO Roadshow (January 2023)IPO roadshow36 slidesJan 13, 2023
IPO Roadshow (November 2022)IPO roadshow36 slidesNov 4, 2022
Investor Presentation (August 2021)Investor deck25 slidesAug 1, 2021

Open Decks

Financings

RaiseDate
At-the-market programme of common stock
Tranche closed: US$5.1M raised
Use of proceeds: Together with existing cash, expected to fund operations into the first quarter of 2027
Nov 16, 2026
Public offering of common stock
Announced: about US$20M · US$3 a share · Lucid Capital Markets
Dealers: Lucid Capital Markets (lead)
Use of proceeds: General corporate purposes, possibly including research and development, clinical trial expenses, capital expenditures and working capital
Jan 8, 2026
Public offering of common stock
Closed: US$10.5M raised · US$3.5 a share · Titan Partners Group, a division of American Capital Partners
Dealers: Titan Partners Group, a division of American Capital Partners (lead)
Use of proceeds: Working capital and general corporate purposes, including continued clinical development of Olvi-Vec
Mar 28, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$6.00 a share on Jan 25, 2023.

Price
US$6.00 a share
Shares offered
2,500,000 shares of common stock
Offering size
US$15 million
Underwriters' option
Up to 375,000 more shares
Underwriters
The Benchmark Company, Brookline Capital Markets · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceMay 7, 2021
Filed publiclyJun 24, 2022
Amended 6 timesNewest Jan 10, 2023
Shares registered with an exchangeJan 23, 2023
Declared effective by the SECJan 25, 2023
Final prospectus, with the priceJan 26, 2023

Open IPO · From the cover of the final prospectus (424B4) filed Jan 26, 2023

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue8.00K8.00K170.0K11.1M00
Cost of revenue574.0K903.0K1.02M968.0K895.0K658.0K477.0K
Gross profit-566.0K-895.0K-848.0K10.1M-895.0K-658.0K-477.0K
Research and development19.9M19.0M12.8M9.08M6.32M6.23M7.53M
Selling, general and administrative13.4M12.7M11.6M5.00M8.29M6.20M3.13M
Operating income-33.2M-31.7M-24.2M-3.01M-14.6M-12.4M-10.9M
Depreciation and amortization244.0K235.0K499.0K553.0K895.0K658.0K477.0K
EBITDA-33.0M-31.5M-23.7M-2.46M-13.7M-11.8M-10.4M
Interest expense0173.0K1.41M1.81M1.22M761.0K
Income before tax-32.1M-29.9M-28.3M-4.11M-16.4M-13.6M-11.6M
Income tax850.1K1.10M1.42M1.22M
Net income-32.1M-29.9M-28.3M-5.21M-17.8M-14.9M-11.6M
Earnings per share, basic-0.86-0.95-1.16-0.57-0.75-0.63-0.49
Earnings per share, diluted-0.86-0.95-1.16-0.57

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents5.33M8.56M9.42M397.0K4.50M11.3M425.0K
Short-term investments9.26M22.3M13.8M0
Current assets15.1M31.5M24.2M1.89M5.82M11.5M551.0K
Property, plant and equipment2.17M1.32M1.17M644.0K2.21M2.45M2.65M
Total assets19.0M34.7M27.9M5.53M8.13M14.0M3.28M
Accounts payable4.36M5.57M3.78M6.78M4.46M927.0K3.63M
Current liabilities6.22M6.90M6.55M31.6M22.5M14.5M14.7M
Long-term debt8.52M18.0M21.7M
Total debt1.69M1.87M2.52M26.4M25.3M26.1M18.0M
Total liabilities7.48M8.44M8.42M41.3M41.2M36.7M28.1M
Shareholders' equity11.5M26.3M19.5M-35.8M-33.1M-22.7M-24.8M
Shares outstanding38.1M34.7M26.8M9.13M23.6M23.6M23.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-25.3M-21.2M-20.3M-3.57M-6.58M-7.21M-7.22M
Capital spending-1.10M-381.0K-1.02M-49.0K-49.0K-20.0K-1.77M
Free cash flow-26.4M-21.6M-21.3M-3.62M-6.63M-7.22M-8.99M
Cash from investing12.1M-8.13M-14.7M-49.0K-49.0K-20.0K-1.77M
Cash from financing9.89M28.5M44.0M-478.0K-270.0K18.1M7.89M
Change in cash-3.23M-853.0K9.02M-4.10M-6.86M10.9M-1.11M

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 16, 2026Quarterly reportSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 4, 2026Big-stake noticeSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
4 · Change in ownershipAug 4, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipAug 4, 2026Insider tradeSEC
4 · Change in ownershipAug 4, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
144 · Notice of proposed saleJul 1, 2026Other filingsSEC
8-K · Current reportJun 22, 2026Meeting outcomeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 2, 2026Insider tradeSEC
144 · Notice of proposed saleJun 1, 2026Other filingsSEC
4 · Change in ownershipMay 12, 2026Insider tradeSEC
4 · Change in ownershipMay 12, 2026Insider tradeSEC
4 · Change in ownershipMay 12, 2026Insider tradeSEC
4 · Change in ownershipMay 12, 2026Insider tradeSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
ARS · Annual report to shareholdersApr 29, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 29, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2026Meeting noticeSEC
4 · Change in ownershipMar 26, 2026Insider tradeSEC
4 · Change in ownershipMar 26, 2026Insider tradeSEC
4 · Change in ownershipMar 26, 2026Insider tradeSEC
4 · Change in ownershipMar 26, 2026Insider tradeSEC
424B5 · ProspectusMar 19, 2026Offer documentSEC
S-8 · Registration statement for employee plansMar 19, 2026Offer documentSEC
8-K · Current reportMar 19, 2026Material contractSEC
10-K · Annual reportMar 19, 2026Annual reportSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
8-K · Current reportFeb 2, 2026Current reportSEC
8-K · Current reportJan 8, 2026Current reportSEC
424B5 · ProspectusJan 8, 2026Offer documentSEC
4 · Change in ownershipJan 7, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 7, 2026Insider tradeSEC
424B5 · ProspectusJan 7, 2026Offer documentSEC
8-K · Current reportJan 5, 2026Current reportSEC
8-K · Current reportJan 2, 2026Management or board changeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
144 · Notice of proposed saleDec 1, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 5, 2025Quarterly reportSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
8-K · Current reportSep 3, 2025Management or board changeSEC
4 · Change in ownershipAug 29, 2025Insider tradeSEC
4 · Change in ownershipAug 29, 2025Insider tradeSEC
4 · Change in ownershipAug 29, 2025Insider tradeSEC
4 · Change in ownershipAug 29, 2025Insider tradeSEC
4 · Change in ownershipAug 29, 2025Insider tradeSEC
4 · Change in ownershipAug 29, 2025Insider tradeSEC
4 · Change in ownershipAug 29, 2025Insider tradeSEC
4 · Change in ownershipAug 29, 2025Insider tradeSEC
S-8 · Registration statement for employee plansAug 7, 2025Offer documentSEC
10-Q · Quarterly reportAug 7, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 25, 2025Big-stake noticeSEC
ARS · Annual report to shareholdersJul 11, 2025Annual reportSEC
DEFA14A · Additional proxy materialJul 11, 2025Meeting noticeSEC
DEF 14A · Proxy statementJul 11, 2025Meeting noticeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
3 · Initial statement of ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
10-Q · Quarterly reportMay 6, 2025Quarterly reportSEC
10-K/A · Annual report, amendedApr 29, 2025Annual reportSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
S-8 · Registration statement for employee plansMar 28, 2025Offer documentSEC
10-K · Annual reportMar 28, 2025Annual reportSEC
424B5 · ProspectusMar 25, 2025Offer documentSEC
8-K · Current reportMar 25, 2025Current reportSEC
FWP · Free writing prospectusMar 25, 2025Offer documentSEC
8-K · Current reportMar 25, 2025ResultsSEC
4 · Change in ownershipFeb 3, 2025Insider tradeSEC
3 · Initial statement of ownershipFeb 3, 2025Insider tradeSEC
8-K · Current reportFeb 3, 2025Management or board changeSEC
4/A · Change in ownership, amendedDec 31, 2024Insider tradeSEC
4/A · Change in ownership, amendedDec 31, 2024Insider tradeSEC
4/A · Change in ownership, amendedDec 31, 2024Insider tradeSEC
4/A · Change in ownership, amendedDec 31, 2024Insider tradeSEC
4 · Change in ownershipDec 30, 2024Insider tradeSEC
144 · Notice of proposed saleDec 30, 2024Other filingsSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
8-K · Current reportNov 8, 2024Current reportSEC
SC 13G · Big-stake noticeOct 25, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedOct 22, 2024Big-stake noticeSEC
4 · Change in ownershipOct 21, 2024Insider tradeSEC
8-K · Current reportOct 3, 2024Management or board changeSEC
4/A · Change in ownership, amendedSep 26, 2024Insider tradeSEC
4 · Change in ownershipSep 13, 2024Insider tradeSEC
4 · Change in ownershipSep 12, 2024Insider tradeSEC
4 · Change in ownershipSep 11, 2024Insider tradeSEC
144 · Notice of proposed saleSep 11, 2024Other filingsSEC
144 · Notice of proposed saleSep 6, 2024Other filingsSEC
4 · Change in ownershipSep 6, 2024Insider tradeSEC
4 · Change in ownershipAug 30, 2024Insider tradeSEC
4 · Change in ownershipAug 27, 2024Insider tradeSEC
144 · Notice of proposed saleAug 22, 2024Other filingsSEC
10-Q · Quarterly reportAug 14, 2024Quarterly reportSEC
8-K · Current reportAug 6, 2024Meeting outcomeSEC
4 · Change in ownershipAug 5, 2024Insider tradeSEC
4 · Change in ownershipAug 5, 2024Insider tradeSEC
4 · Change in ownershipAug 5, 2024Insider tradeSEC
4 · Change in ownershipAug 5, 2024Insider tradeSEC
8-K · Current reportAug 1, 2024Current reportSEC
4 · Change in ownershipJul 8, 2024Insider tradeSEC
4 · Change in ownershipJul 8, 2024Insider tradeSEC
4 · Change in ownershipJul 8, 2024Insider tradeSEC
4 · Change in ownershipJul 8, 2024Insider tradeSEC
4 · Change in ownershipJul 8, 2024Insider tradeSEC
4 · Change in ownershipJul 8, 2024Insider tradeSEC
4 · Change in ownershipJul 8, 2024Insider tradeSEC
ARS · Annual report to shareholdersJun 14, 2024Annual reportSEC
DEFA14A · Additional proxy materialJun 14, 2024Meeting noticeSEC
DEF 14A · Proxy statementJun 14, 2024Meeting noticeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
8-K · Current reportJun 4, 2024Current reportSEC
424B5 · ProspectusMay 24, 2024Offer documentSEC
8-K · Current reportMay 24, 2024Material contractSEC
424B5 · ProspectusMay 23, 2024Offer documentSEC
4 · Change in ownershipMay 15, 2024Insider tradeSEC
4 · Change in ownershipMay 9, 2024Insider tradeSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
4 · Change in ownershipMay 1, 2024Insider tradeSEC
4 · Change in ownershipApr 24, 2024Insider tradeSEC
4 · Change in ownershipApr 18, 2024Insider tradeSEC
144/A · Notice of proposed sale, amendedApr 15, 2024Other filingsSEC
144 · Notice of proposed saleApr 11, 2024Other filingsSEC
8-K · Current reportApr 9, 2024Current reportSEC
8-K · Current reportApr 1, 2024Current reportSEC
S-8 · Registration statement for employee plansMar 29, 2024Offer documentSEC
10-K · Annual reportMar 29, 2024Annual reportSEC
EFFECT · Notice that a registration is effectiveFeb 14, 2024Other filingsSEC
CORRESP · Letter to the SECFeb 8, 2024Other filingsSEC
UPLOAD · Letter from the SECFeb 8, 2024Other filingsSEC
8-K · Current reportFeb 5, 2024Current reportSEC
8-K · Current reportFeb 2, 2024ResultsSEC
S-3 · Registration statementFeb 2, 2024Offer documentSEC
SC 13G · Big-stake noticeFeb 2, 2024Big-stake noticeSEC
4 · Change in ownershipDec 18, 2023Insider tradeSEC
144 · Notice of proposed saleDec 15, 2023Other filingsSEC
4 · Change in ownershipDec 14, 2023Insider tradeSEC
4 · Change in ownershipDec 14, 2023Insider tradeSEC
144 · Notice of proposed saleDec 13, 2023Other filingsSEC
144 · Notice of proposed saleDec 13, 2023Other filingsSEC
8-K · Current reportDec 12, 2023Current reportSEC
4 · Change in ownershipDec 8, 2023Insider tradeSEC
144 · Notice of proposed saleDec 7, 2023Other filingsSEC
8-K · Current reportNov 24, 2023Management or board changeSEC
4 · Change in ownershipNov 22, 2023Insider tradeSEC
4 · Change in ownershipNov 21, 2023Insider tradeSEC
144 · Notice of proposed saleNov 17, 2023Other filingsSEC
S-8 · Registration statement for employee plansNov 14, 2023Offer documentSEC

This page holds 200 of 363 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Genelux Corporation’s releases · as of Nov 16, 2026

Common shares
48,064,184
Fully diluted
48,064,184

Fully diluted

LineSharesAs of
Common shares48,064,184Nov 11, 2026

Share count over time

CountShares
Nov 11, 202648,064,184

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Woodward Diversified Capital, LLC2.38M4.9%US$6.02MSep 30, 2026
Vanguard1.93M4.0%US$4.89MSep 30, 2026
Bleichroeder LP1.38M2.9%US$3.49MSep 30, 2026
BlackRock433K0.90%US$1.1MSep 30, 2026
Geode Capital429K0.89%US$1.08MSep 30, 2026
CM Management, LLC400K0.83%US$1.01MSep 30, 2026
Two Sigma300K0.62%US$759KSep 30, 2026
Global Retirement Partners, LLC228K0.47%US$576KSep 30, 2026
LPL Financial LLC157K0.33%US$398KSep 30, 2026
State Street146K0.30%US$369KSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Provident Wealth Management, LLC145K0.30%US$367KSep 30, 2026
UBS139K0.29%US$351KSep 30, 2026
LifeSteps Financial, Inc.124K0.26%US$312KSep 30, 2026
Osaic Holdings, Inc.122K0.25%US$307KSep 30, 2026
Morgan Stanley118K0.24%US$298KSep 30, 2026
Wealth Enhancement Advisory Services, LLC108K0.22%US$270KSep 30, 2026
Renaissance Technologies99,8110.21%US$253KSep 30, 2026
Citadel98,5780.21%US$249KSep 30, 2026
Marshall Wace, LLP97,9210.20%US$248KSep 30, 2026
Northern Trust89,2790.19%US$226KSep 30, 2026
SteelPeak Wealth, LLC75,8950.16%US$192KSep 30, 2026
Susquehanna75,5620.16%US$191KSep 30, 2026
AMG National Trust Bank75,3510.16%US$191KSep 30, 2026
Falcon Wealth Planning63,2000.13%US$160KSep 30, 2026
Trek Financial, LLC62,4340.13%US$158KSep 30, 2026
Pavaki Capital Management LLC60,0000.12%US$152KSep 30, 2026
Goldman Sachs59,7270.12%US$151KSep 30, 2026
Mariner, LLC52,8660.11%US$134KSep 30, 2026
XTX Topco Ltd50,0210.10%US$127KSep 30, 2026
Walleye Capital LLC44,2250.09%US$112KSep 30, 2026
Quadrature Capital Ltd43,8740.09%US$111KSep 30, 2026
Squarepoint Ops LLC42,3460.09%US$107KSep 30, 2026
Strive Financial Group ,LLC41,3700.09%US$105KSep 30, 2026
Richard Young Associates, Ltd.40,9590.09%US$104KSep 30, 2026
Creative Planning36,2360.08%US$91,677Sep 30, 2026
Raymond James Financial Inc35,8050.07%US$90,586Sep 30, 2026
Waystone Advisors LLC33,3320.07%US$100KSep 30, 2026
One Capital Management, LLC30,8830.06%US$78,133Sep 30, 2026
Axq Capital, LP29,2420.06%US$73,982Sep 30, 2026
KWB Wealth23,3270.05%US$59,017Sep 30, 2026
Schonfeld Strategic Advisors LLC23,1060.05%US$58,457Sep 30, 2026
D.A. Davidson & Co.21,7790.05%US$55,101Sep 30, 2026
Point72 Asset Management, L.P.20,8580.04%US$52,771Sep 30, 2026
Apollon Wealth Management, LLC20,2840.04%US$51,319Sep 30, 2026
5T Wealth, LLC18,5010.04%US$46,807Sep 30, 2026
Millennium18,0650.04%US$45,704Sep 30, 2026
Integrity Alliance, LLC.17,7520.04%US$44,913Sep 30, 2026
Liberty Wealth Management LLC16,5470.03%US$41,864Sep 30, 2026
Prime Capital Investment Advisors, LLC15,6730.03%US$39,654Sep 30, 2026
Grange Capital, LLC14,7250.03%US$37,254Sep 30, 2026

This page holds 50 of 76 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund1.19M2.5%US$3.59MJun 30, 2026
Vanguard Extended Market Index Fund467K0.97%US$1.41MJun 30, 2026
Fidelity Extended Market Index Fund211K0.44%US$644KMay 31, 2026
iShares Micro-Cap ETF138K0.29%US$416KJun 30, 2026
Fidelity Total Market Index Fund62,1370.13%US$190KMay 31, 2026
Fidelity Series Total Market Index Fund58,2980.12%US$178KMay 31, 2026
Goldman Sachs Absolute Return Tracker Fund34,3230.07%US$103KJun 30, 2026
Fidelity Nasdaq Composite Index Fund26,0330.05%US$79,401May 31, 2026
Schwab Total Stock Market Index Fund25,0000.05%US$73,500Jul 31, 2026
Vanguard Institutional Total Stock Market Index Fund16,7290.03%US$50,354Jun 30, 2026
All 13 holders
HolderSharesOf the companyValueAs of
1290 VT Micro Cap Portfolio9,2990.02%US$27,990Jun 30, 2026
Victory Extended Market Index Fund4,629<0.01%US$13,609Jul 31, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND228<0.01%US$670Jul 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Yu Yong
Officer: Chief Scientific Officer
Sale668USD 2.01US$1,344Nov 3, 2026
Zindrick Thomas
Officer: President and CEO
Sale3,089USD 2.05US$6,317Nov 3, 2026
Cappello Joseph
Officer: Chief Technical Officer
Sale668USD 2.04US$1,363Nov 3, 2026
Yu Yong
Officer: Chief Scientific Officer
Sale9,683USD 2.75US$26,628Aug 31, 2026
Zindrick Thomas
Officer: President and CEO
Sale34,463USD 2.67US$92,016Aug 31, 2026
Cappello Joseph
Officer: Chief Technical Officer
Sale10,257USD 2.74US$28,104Aug 31, 2026
Zindrick Thomas
Officer: President and CEO
Sale3,023USD 2.95US$8,918Aug 4, 2026
Cappello Joseph
Officer: Chief Technical Officer
Sale653USD 2.95US$1,926Aug 4, 2026
Yu Yong
Officer: Chief Scientific Officer
Sale653USD 2.94US$1,920Aug 4, 2026
Smither John W
Director
Sale12,000USD 2.91US$34,920Jul 1, 2026
All 16 trades
TradeTradeSharesPriceValueDate
Smalling Ralph
Officer: Head of Regulatory
Sale192USD 2.93US$563Jun 3, 2026
Thomas John
Director
Sale10,000USD 2.98US$29,800Jun 1, 2026
Smalling Ralph
Officer: Head of Regulatory
Sale270USD 2.98US$805May 11, 2026
Zindrick Thomas
Officer: President and CEO
Sale2,798USD 2.94US$8,226May 11, 2026
Yu Yong
Officer: Chief Scientific Officer
Sale605USD 2.97US$1,797May 11, 2026
Cappello Joseph
Officer: Chief Technical Officer
Sale605USD 2.97US$1,797May 11, 2026

Big stakes

StakeStakeSharesDateFiling
Armistice Capital, LLC9.99%4.22MSep 30, 2025Schedule 13G
Aladar Szalay6.20%2.83MSep 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John Smither
Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); MBX Biosciences, Inc. (Chief Financial Officer · Since at least Mar 16, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Applied Molecular Transport Inc (Director · Jan 27, 2022 – Dec 27, 2023 · Past); eFFECTOR Therapeutics Inc (Director · Aug 25, 2020 – Jun 22, 2023 · Past); Arcutis Biotherapeutics, Inc. (Chief Financial Officer · Jan 30, 2020 – Feb 13, 2024 · Past); Principia Biopharma Inc (Director · Feb 19, 2019 – Feb 19, 2019 · Past); Achaogen Inc (Director · Mar 11, 2014 – Jun 5, 2018 · Past); Kythera Biopharmaceuticals Inc (Chief Financial Officer · Oct 10, 2012 – Oct 1, 2015 · Past)
Chair, Compensation Committee · Since at least Sep 11, 2023
Eric Groen
Other companies: Rani Therapeutics Holdings, Inc. (General Counsel · Mar 22, 2022 – Mar 21, 2024 · Past)
General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development · Since at least Jul 1, 2025
Caroline JewettHead of Quality · Jun 30, 2023 – Feb 19, 2024 · Past
Gabe WoodwardDirector · Jan 25, 2023 – Feb 17, 2023 · Past
James L. TyreeLead Independent Director · Since at least Aug 27, 2025
Jason LittenChief Medical Officer · Since at least Sep 9, 2026
John ThomasDirector · Since at least Jan 25, 2023
Joseph CappelloChief Technical Officer · Since at least Mar 14, 2025
Lourie S ZakChief Financial Officer · Aug 28, 2023 – Dec 18, 2024 · Past
Mary MirabelliDirector · Since at least Jun 16, 2026
All 16 people
PersonSeat
Matt PulisicChief Financial Officer · Since at least Jan 12, 2026
Qian ZhangVice President, Clinical Sciences · Since at least Nov 5, 2026
Ralph SmallingVice President, Head of Regulatory Affairs · Since at least Jun 4, 2026
Sean RyderGeneral Counsel · Jan 25, 2023 – May 12, 2025 · Past
Thomas ZindrickPresident and Chief Executive Officer · Since at least May 11, 2026
Tony YuChief Scientific Officer · Since at least Nov 4, 2026

Open People

Log in to ask 6ix AI your own questions about Genelux Corporation.